Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 12, 2011, Pages 1779-1787

  Marioni, Gino ^a   Blandamura, Stella ^a   Loreggian, Lucio ^b   Koussis, Haralabos ^b   Lionello, Marco ^a   Giacomelli, Luciano ^a   Fasanaro, Elena ^a   Lovato, Andrea ^a   Staffieri, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Angiogenin; CD105; Laryngeal carcinoma; Postoperative RT; Prognosis

Indexed keywords

ANGIOGENIN; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNGECTOMY; LARYNX CARCINOMA; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; RIBONUCLEASE, PANCREATIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 83655192010     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1743-3     Document Type: Article

References (25)

1. MC De Jong J Pramana JE Van der Wal, et al. 2010 CD44 expression predicts local recurrence after radiotherapy in larynx cancer Clin Cancer Res 16 5329 5338 20837694 10.1158/1078-0432.CCR-10-0799
2. M Baumann M Krause 2010 CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy Clin Cancer Res 16 5091 5093 20861165 10.1158/1078-0432.CCR-10-2244 1:CAS:528:DC%2BC3cXhtl2rsL3O
3. D Liao RS Johnson 2007 Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev 26 281 290 17603752 10.1007/s10555-007-9066-y 1:CAS:528:DC%2BD2sXotFWrtLw%3D (Pubitemid 47101669)
4. E Fonsatti M Altomonte MR Nicotra PG Natali M Maio 2003 Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels Oncogene 22 6557 6563 14528280 10.1038/sj.onc.1206813 1:CAS:528: DC%2BD3sXnsl2rs78%3D (Pubitemid 37372335)
5. KA Dickson DK Kang YS Kwon, et al. 2009 Ribonuclease inhibitor regulates neovascularization by human angiogenin Biochemistry 48 3804 3806 19354288 10.1021/bi9005094 1:CAS:528:DC%2BD1MXkslaksbk%3D
6. CM West L Joseph S Bhana 2008 Epidermal growth factor receptor-targeted therapy Br J Radiol 81 Spec No 1 S36 S44 18819997 10.1259/bjr/32798755
7. A De Luca A Carotenuto A Rachiglio, et al. 2008 The role of the EGFR signaling in tumor microenvironment J Cell Physiol 214 559 567 17894407 10.1002/jcp.21260 (Pubitemid 351224199)
8. L Licitra L Locati P Bossi 2006 Biological agents in head and neck cancer Ann Oncol 17 Suppl 10 x45 x48 17018750 10.1093/annonc/mdl235 (Pubitemid 44541985)
9. G Marioni R Marchese-Ragona G Cartei F Marchese A Staffieri 2006 Current opinion in diagnosis and treatment of laryngeal carcinoma Cancer Treat Rev 32 504 515 16920269 10.1016/j.ctrv.2006.07.002 (Pubitemid 44488046)
10. Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Oxford
11. H Jiang BB Yang 2009 p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy Acta Otolaryngol (Stockh) 129 101 107 10.1080/00016480802054185 1:CAS:528:DC%2BD1cXhsFWmsbjN
12. G Marioni A Staffieri M Savastano, et al. 2011 Angiogenin expression in head and neck basaloid and conventional squamous cell carcinoma: a site- and stage-matched comparison J Oral Pathol Med 40 55 60 20923443 10.1111/j.1600-0714.2010.00942.x
13. G Marioni F Marino S Blandamura, et al. 2010 Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival Histopathology 57 535 543 20955379 10.1111/j.1365-2559.2010.03664.x
14. G Almadori G Cadoni J Galli, et al. 1999 Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse Int J Cancer 84 188 191 10096253 10.1002/(SICI)1097- 0215(19990420)84:2<188::AID-IJC16>3.0.CO;2-1 1:STN:280: DyaK1M7ptl2itQ%3D%3D (Pubitemid 29133831)
15. K Vlachtsis A Nikolaou K Markou G Fountzilas I Daniilidis 2005 Clinical and molecular prognostic factors in operable laryngeal cancer Eur Arch Otorhinolaryngol 262 890 898 15739081 10.1007/s00405-005-0916-3 (Pubitemid 41779880)
16. X Pivot N Magné E Guardiola, et al. 2005 Prognostic impact of epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer Oral Oncol 41 320 327 15743695 10.1016/j.oraloncology.2004.09.011 1:CAS:528:DC%2BD2MXhvVGjsbc%3D (Pubitemid 40320461)
17. G Marioni A Staffieri A Bertolin, et al. 2010 Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases Eur Arch Otorhinolaryngol 267 1103 1110 20052590 10.1007/s00405-009-1186-2
18. G Marioni E D'Alessandro L Giacomelli A Staffieri 2010 CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma J Oral Pathol Med 39 361 367 20537053 10.1111/j.1600-0714.2009.00868.x 1:CAS:528:DC%2BC3cXnsF2ns74%3D
19. G Marioni G Ottaviano L Giacomelli, et al. 2006 CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma Eur J Surg Oncol 32 1149 1153 16979866 10.1016/j.ejso.2006.08.001 1:STN:280:DC%2BD28novVCjtg%3D%3D (Pubitemid 44774411)
20. G Marioni E D'Alessandro L Giacomelli, et al. 2006 Maspin nuclear localization is related to reduced density of tumour-associated microvessels in laryngeal carcinoma Anticancer Res 26 4927 4932 17214364 1:CAS:528: DC%2BD2sXps1Sruw%3D%3D (Pubitemid 46032136)
21. G Marioni R Marchese-Ragona M Lucioni A Staffieri 2008 Organ-preservation surgery following failed radiotherapy for laryngeal cancer. Evaluation, patient selection, functional outcome and survival Curr Opinion Otolaryngol Head Neck Surg 16 141 146 10.1097/MOO.0b013e3282f495a2 (Pubitemid 351354969)
22. F Tanaka S Ishikawa K Yanagihara, et al. 2002 Expression of angiopoietins and its clinical significance in non-small cell lung cancer Cancer Res 62 7124 7129 12460935 1:CAS:528:DC%2BD38XpsVaht78%3D (Pubitemid 35424109)
23. V Hofmeister C Vetter D Schrama E-B Brocker JC Becker 2006 Tumor stroma-associated antigens for anti-cancer immunotherapy Cancer Immunol Immunother 55 481 494 16220326 10.1007/s00262-005-0070-1
24. V Hofmeister D Schrama JC Becker 2008 Anti-cancer therapies targeting the tumor stroma Cancer Immunol Immunother 57 1 17 17661033 10.1007/s00262-007- 0365-5 1:CAS:528:DC%2BD2sXht1aqs77L (Pubitemid 350043655)
25. E Fonsatti M Maio 2004 Highlights on endoglin (CD105): from basic findings towards clinical application in human cancer J Transl Med 2 18 15193152 10.1186/1479-5876-2-18 (Pubitemid 39130354)